Solid Biosciences joined PPMD for a community webinar to provide an update on the INSPIRE DUCHENNE clinical trial for SGT-003, a next-generation microdystrophin gene therapy for individuals living with Duchenne. Included in the update were details about the current progress in the study and efforts underway to expand eligibility criteria and participating clinical trial sites.